U.S. To Invest $170M In Completing Research On Experimental Ebola Vaccines, Drugs

Oct 02, 2017

Reuters: U.S. invests $170 million in late-stage Ebola vaccines, drugs
“The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Administration. The Biomedical Advanced Research and Development Authority (BARDA), part of the department of Health and Human Services, said on Friday it would buy the drugs and vaccines and keep them in a national stockpile, which would be used to protect Americans in the event of an outbreak of the deadly disease…” (Steenhuysen, 9/29).